Cathepsin B, His, Human
Alternative product(s) for purchase:Z03577
| $165.00 | |
| Z03322-10 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
Alternative product(s) for purchase:Z03577
| $165.00 | |
| Z03322-10 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Species | Human | ||||
| Protein Construction |
|
||||
| Purity | > 95% as analyzed by SDS-PAGE | ||||
| Endotoxin Level | < 0.2 EU/μg of protein by gel clotting method | ||||
| Expression System | CHO | ||||
| Apparent Molecular Weight | ~43 kDa, on SDS-PAGE under reducing conditions. | ||||
| Formulation | Supplied as a 0.2 μm filtered solution in 25 mM Tris, 150 mM NaCl, 20% Glycerol, pH 8.0. | ||||
| Concentration | Please refer to the COA for the specific lot. | ||||
| Storage & Stability | Upon receiving, this product remains stable for 6 months at -20°C or below and 1-2 weeks at 4°C. For long term storage, aliquot and store at -70°C or below. Avoid repeated freeze-thaw cycles. |
| Target Background | Cathepsin B is an enzymatic protein that is a member of the peptidase (or protease) family. Elevated lev- els of cathepsin B occur in a wide variety of disease,causing numerous pathologies including cell death, inflammation, and the production of toxic peptides. For example, neuroscience research suggests that cathepsin B plays a role in inducing epilepsy resulting in a significant amount of cell death. Seizure-induced rats treated with a cathepsin B inhibitor exhibited improved neurological scores and learning ability with reduced neuronal cell death. |
| Synonyms | Cathepsin B; APP secretase; APPS |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.